13F

Stock

Agomab Therapeutics Nv

AGMB · held by 32 managers

Reported value

$245M

Holders

32

+32 new · −0 exited

Holders’ est. mark

—

Need a prior quarter

Largest holder

$53.9M

EQT Fund Management S.a r.l.

Notable conviction

Share of each notable manager’s 13F book.

Who holds it

Notable only
InvestorSharesValueEst. markChange
EQT Fund Management S.a r.l.5.14M$53.9M—New
Sanofi2.78M$29.2M—New
Cormorant Asset Management, LP2.47M$25.9M—New
TCG Crossover Management, LLC2.05M$21.5M—New
FEDERATED HERMES, INC.1.62M$17M—New
Casdin Capital, LLC1.55M$16.3M—New
ANDERA PARTNERS1.54M$16.1M—New
Fidelity1.46M$15.3M—New
Nantahala Capital Management, LLC1.2M$12.9M—New
Aberdeen Group plc707.7K$7.42M—New
PERCEPTIVE ADVISORS LLC600K$6.29M—New
SAMSARA BIOCAPITAL, LLC600K$6.29M—New
Siren, L.L.C.411.3K$4.31M—New
LMR Partners LLP300K$3.15M—New
SEVEN GRAND MANAGERS, LLC200K$2.1M—New
Redmile Group, LLC156.3K$1.64M—New
MILLENNIUM MANAGEMENT LLC95.2K$999K—New
Pfizer Inc75K$813.8K—New
Alyeska Investment Group, L.P.75K$786.8K—New
Bellevue Group AG50K$524.5K—New
Laurion Capital Management LP50K$524.5K—New
SECTORAL ASSET MANAGEMENT INC43.5K$477.3K—New
GOLDMAN SACHS GROUP INC35.7K$374.9K—New
Citadel35K$367.1K—New
BURKEHILL GLOBAL MANAGEMENT, LP35K$367.1K—New
D. E. Shaw & Co., Inc.15.3K$160.8K—New
TWO SIGMA INVESTMENTS, LP14.2K$149.4K—New
JANE STREET GROUP, LLC12.8K$134.2K—New
UBS Group AG6.44K$67.5K—New
MORGAN STANLEY3.02K$31.7K—New
HRT FINANCIAL LP23.7K$248—New
SBI Securities Co., Ltd.2$21—New

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.